Sign up for your ticket to see PharmData at the Pharmacy Show for a chance to win a £100 Amazon voucher!
2014-12-17 14:56:43 (10 year(s) ago)
(Eli Lilly) Recall following clinical trial findings showing lack of efficacy and risk/benefit concerns – class 1 action now. (EL (14)A/15)
Read full MHRA article